Association of Serum Macrophage Migration Inhibitory Factor with 3-Month Poor Outcome and Malignant Cerebral Edema in Patients with Large Hemispheric Infarction-Reference-Cited by-同舟云学术

Association of Serum Macrophage Migration Inhibitory Factor with 3-Month Poor Outcome and Malignant Cerebral Edema in Patients with Large Hemispheric Infarction

Published:2024-04-01 Issue:2 Volume:41 Page:558-567
ISSN:1541-6933
Container-title:Neurocritical Care
language:en
Short-container-title:Neurocrit Care

Author:

Guo Wen,Xu Mangmang,Song Xindi,Cheng Yajun,Deng Yilun,Liu Ming^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12028-024-01958-8.pdf

Reference30 articles.

1. Heiss WD, Malignant MCA. Infarction: pathophysiology and imaging for early diagnosis and management decisions. Cerebrovasc Dis (Basel, Switzerland). 2016;41:1–7. https://doi.org/10.1159/000441627.

2. Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–596. https://doi.org/10.1161/CIR.0000000000000757.

3. Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1222–38. https://doi.org/10.1161/01.str.0000441965.15164.d6.

4. Vorasayan P, Bevers MB, Beslow LA, et al. Intravenous Glibenclamide reduces lesional water uptake in large hemispheric infarction. Stroke. 2019;50:3021–7. https://doi.org/10.1161/STROKEAHA.119.026036.

5. Cheng Y, Wu S, Wang Y, et al. External validation and modification of the EDEMA score for predicting malignant brain edema after acute ischemic stroke. Neurocrit Care. 2020;32:104–12. https://doi.org/10.1007/s12028-019-00844-y.